BeStock  
Stocks › Biotechnology › GENB

Generate Biomedicines GENB

US equityMarket cap rank #3024Biotechnology
$9.54 −$0.83 (-8.00%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $9.90 +3.77%
Open$10.06
Prev close$10.37
Day range$9.40 – $10.58
Volume967.9K
Market cap$1.23B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.4x
CheapRich

Above its usual level · 69th percentile, 5-year average -6.7x

Price / book4.1x
CheapRich

Above its usual level · 75th percentile, 5-year average 2.1x

#4154 of 5330 stocks by PB (1 = cheapest)

Price / sales74.0x
CheapRich

Near the top of its 5-year range · 83rd percentile, 5-year average 60.8x

#4912 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-11x-7x-3x1xFeb '26Jul '26Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$16.33
Price vs. fair value-41.6%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.09 – 2.07 75% (pricier than usual) #4154 of 5330 (1 = cheapest)
PE -6.36 -4.11 -6.74 69% (pricier than usual) –
PS 73.96 53.52 60.78 83% (pricier than usual) #4912 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on GENB.

Sign in to join the discussion.

Scroll to Top